Literature DB >> 4623003

Synthesis and distribution of a radiolabeled antitumor agent: cis-diamminedichloroplatinum. II.

R C Lange, R P Spencer, H C Harder.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4623003

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  11 in total

1.  Preclinical imaging characteristics and quantification of Platinum-195m SPECT.

Authors:  E A Aalbersberg; B J de Wit-van der Veen; O Zwaagstra; K Codée-van der Schilden; E Vegt; Wouter V Vogel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-02-11       Impact factor: 9.236

2.  Transient blindness and seizure associated with cisplatin therapy.

Authors:  M T Cattaneo; V Filipazzi; E Piazza; E Damiani; G Mancarella
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

Review 3.  Antineoplastic drugs: clinical pharmacology and therapeutic use.

Authors:  R A Bender; L A Zwelling; J H Doroshow; G Y Locker; K R Hande; D S Murinson; M Cohen; C E Myers; B A Chabner
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

Review 4.  Platinum antitumour agents: a review of (bio)analysis.

Authors:  T J Hodes; W J Underberg; G Los; J H Beijnen
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

5.  Supraophthalmic carotid infusion for recurrent glioma: rationale, technique, and preliminary results for cisplatin and BCNU.

Authors:  J P Kapp; R B Vance
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

6.  Permeability change and brain tissue damage after intracarotid administration of cisplatin studied by double-tracer autoradiography in rats.

Authors:  S Sugimoto; Y L Yamamoto; S Nagahiro; M Diksic
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

7.  Pharmacokinetic study of cerebrospinal fluid penetration of cis-diamminedichloroplatinum (II).

Authors:  P E Gormley; D Gangji; J H Wood; D G Poplack
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

8.  Comparative distribution and excretion of carboplatin and cisplatin in mice.

Authors:  Z H Siddik; M Jones; F E Boxall; K R Harrap
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

9.  Increased CT density of the liver due to cis-diaminedichloro platinum (II).

Authors:  T Aihara; M Fujioka; K Yamamoto
Journal:  Pediatr Radiol       Date:  1987

10.  Suramin protects from cisplatin-induced acute kidney injury.

Authors:  Tess V Dupre; Mark A Doll; Parag P Shah; Cierra N Sharp; Alex Kiefer; Michael T Scherzer; Kumar Saurabh; Doug Saforo; Deanna Siow; Lavona Casson; Gavin E Arteel; Alfred Bennett Jenson; Judit Megyesi; Rick G Schnellmann; Levi J Beverly; Leah J Siskind
Journal:  Am J Physiol Renal Physiol       Date:  2015-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.